10-Q 1 l95357ae10vq.txt N-VIRO INTERNATIONAL CORPORATION 10-Q/6-30-2002 ================================================================================ UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (MARK ONE) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2002 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM ____________ TO ____________ COMMISSION FILE NUMBER: 0-21802 ----------- N-VIRO INTERNATIONAL CORPORATION (EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER) DELAWARE 34-1741211 (STATE OR OTHER JURISDICTION OF (IRS EMPLOYER IDENTIFICATION NO.) INCORPORATION OR ORGANIZATION) 3450 W. CENTRAL AVENUE, SUITE 328 TOLEDO, OHIO 43606 (ADDRESS OF PRINCIPAL EXECUTIVE OFFICES) (ZIP CODE) REGISTRANT'S TELEPHONE NUMBER, INCLUDING AREA CODE: (419) 535-6374 ----------- Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to the filing requirements for at least the past 90 days. Yes X No . --- --- As of August 9, 2002, 2,577,433 shares of N-Viro International Corporation $ .01 par value common stock were outstanding. ================================================================================ -1- PART I - FINANCIAL INFORMATION ITEM 1. FINANCIAL STATEMENTS N-VIRO INTERNATIONAL CORPORATION CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)
Three Months Ended June 30 Six Months Ended June 30 2002 2001 2002 2001 ------------------------------- -------------------------------- Revenues $ 1,240,414 $ 1,115,478 $ 2,658,193 $ 2,278,242 Cost of revenues 878,188 642,615 1,826,054 1,396,358 ----------- ----------- ----------- ----------- Gross Profit 362,226 472,863 832,139 881,884 Operating expenses: Selling, general and administrative 512,118 498,965 981,869 1,046,437 Patent litigation expense - 131,764 545 201,940 ----------- ----------- ----------- ----------- 512,118 630,729 982,414 1,248,377 ----------- ----------- ----------- ----------- Operating loss (149,892) (157,866) (150,275) (366,493) Nonoperating income (expense): Interest income (expense), net (4,097) 6,338 (4,306) 5,694 Income (loss) from equity investment in joint venture 27,616 (51,630) 52,262 (62,095) ----------- ----------- ----------- ----------- 23,519 (45,292) 47,956 (56,401) ----------- ----------- ----------- ----------- Income (loss) before income taxes (126,373) (203,158) (102,319) (422,894) Federal and state income taxes - - - - ----------- ----------- ----------- ----------- Net income (loss) $ (126,373) $ (203,158) $ (102,319) $ (422,894) =========== =========== =========== =========== Basic and diluted earnings (loss) per share $ (0.05) $ (0.08) $ (0.04) $ (0.16) =========== =========== =========== =========== Weighted average common shares outstanding 2,577,433 2,643,683 2,577,433 2,643,683 =========== =========== =========== ===========
See Notes to Consolidated Financial Statements -2- N-VIRO INTERNATIONAL CORPORATION CONSOLIDATED BALANCE SHEETS
June 30, 2002 December 31, (Unaudited) 2001 (Audited) --------------- -------------- ASSETS ------ CURRENT ASSETS Cash and cash equivalents: Unrestricted $ 43,866 $ 45,427 Restricted 400,000 400,000 Securities available-for-sale 1,401 1,401 Receivables: Trade, net of allowance of $87,501 788,125 854,011 Notes and other 22,800 22,000 Related parties 25,561 24,461 Prepaid expenses and other assets 150,807 49,757 ------------ ------------ Total current assets 1,432,560 1,397,057 Property and Equipment 621,460 479,541 Investment in Florida N-Viro, L.P. 577,348 525,086 Intangible and Other Assets 1,704,172 1,731,647 ------------ ------------ $ 4,335,540 $ 4,133,331 ============ ============ LIABILITIES AND STOCKHOLDERS' EQUITY ------------------------------------ CURRENT LIABILITIES Current maturities of long-term debt $ 374,342 $ 438,534 Line-of-credit 610,000 503,613 Accounts payable 1,155,949 991,344 Accrued liabilities 412,565 418,926 ------------ ------------ Total current liabilities 2,552,856 2,352,417 Long-term debt, less current maturities 564,430 460,342 COMMITMENTS AND CONTINGENCIES STOCKHOLDERS' EQUITY Common stock, $.01 par value; authorized 7,000,000 shares; issued 2,700,933 shares 27,010 27,010 Additional paid-in capital 13,495,602 13,495,602 Retained earnings (deficit) (11,619,468) (11,517,150) ------------ ------------ 1,903,144 2,005,462 Less treasury stock, at cost, 123,500 shares 684,890 684,890 ------------ ------------ Total stockholders' equity 1,218,254 1,320,572 ------------ ------------ $ 4,335,540 $ 4,133,331 ============ ============
See Notes to Consolidated Financial Statements -3- N-VIRO INTERNATIONAL CORPORATION CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)
Six Months Ended June 30, 2002 2001 --------- ---------- NET CASH PROVIDED BY OPERATING ACTIVITIES $ 105,417 $ 19,745 CASH FLOWS FROM INVESTING ACTIVITIES Collections on notes receivable 3,271 - Increase in notes receivable - (195,718) Advances to related parties (1,100) - Purchases of property and equipment (23,527) (3,460) Expenditures for intangible assets (53,063) (20,702) --------- --------- Net cash used in investing activities (74,419) (219,880) CASH FLOWS FROM FINANCING ACTIVITIES Net borrowings on line-of-credit 106,387 165,000 Borrowings under long-term obligations 71,811 58,736 Principal payments on long-term obligations (210,757) (70,756) --------- --------- Net cash provided (used) by financing activities (32,559) 152,980 --------- --------- NET DECREASE IN CASH AND CASH EQUIVALENTS (1,561) (47,155) CASH AND CASH EQUIVALENTS - BEGINNING 45,427 128,485 --------- --------- CASH AND CASH EQUIVALENTS - ENDING $ 43,866 $ 81,330 ========= =========
Non-cash investing and financing activities: During the six months ended June 30, 2002, the Company borrowed $178,842 to finance the purchase of equipment. -4- N-VIRO INTERNATIONAL CORPORATION AND SUBSIDIARIES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) 1. ORGANIZATION AND BASIS OF PRESENTATION The accompanying consolidated financial statements of N-Viro International Corporation (the "Company") are unaudited but, in management's opinion, reflect all adjustments (including normal recurring accruals) necessary to present fairly such information for the period and at the dates indicated. The results of operations for the six months ended June 30, 2002 may not be indicative of the results of operations for the year ended December 31, 2002. Since the accompanying consolidated financial statements have been prepared in accordance with Article 10 of Regulation S-X, they do not contain all information and footnotes normally contained in annual consolidated financial statements; accordingly, they should be read in conjunction with the consolidated financial statements and notes thereto appearing in the Company's Form 10-K for the period ending December 31, 2001. The financial statements are consolidated as of June 30, 2002 and December 31, 2001 for the Company. Adjustments have been made to eliminate all intercompany transactions. In preparing financial statements in conformity with accounting principles generally accepted in the United States of America, management makes estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. The following are certain significant estimates and assumptions made in preparation of the financial statements: Non-domestic license and territory fees - The Company does not recognize revenue on any non-domestic license or territory fee contracts until the cash is received, assuming all other tests of revenue recognition are met. Canada is excluded from this definition of non-domestic. Allowance for Doubtful Accounts - The Company estimates losses for uncollectible accounts based on the aging of the accounts receivable and the evaluation of the likelihood of success in collecting the receivable. Income Taxes - The Company assumes the deductibility of certain costs in income tax filings and estimates the recovery of deferred income tax assets. 2. RELATED PARTY TRANSACTIONS The Company recognized an expense to Mr. Bobby B. Carroll, a Director of the Company and a former shareholder of Tennessee-Carolina N-Viro, Inc., of $30,000 for the six months ended June 30, 2002 under a contract arrangement signed in 1993 and amended in 1998 for consulting services. To secure this obligation, the Company granted Mr. Carroll a security interest in all present and future receivables and contract rights from licenses in the states of Tennessee, North Carolina and South Carolina pursuant to the contract agreement. -5- 3. CONTINGENCIES In November, 2001, and as filed under Form 8-K dated December 14, 2001, the Company and Hydropress Environmental Services, Inc. ("Hydropress") signed a settlement agreement (the "Settlement Agreement") of a lawsuit between the parties related to alleged price guarantees on shares of the Company's common stock and to alleged breaches of a license agreement between the parties. Each party dismissed its claims against the other with prejudice and entered into general releases in favor of the other party. Pursuant to the terms of the Settlement Agreement, among other things, N-Viro purchased back 66,250 N-Viro shares held by Hydropress at the market price as of November 15, 2001, which was $1.01 per share, for a total of $66,913. Also pursuant to the Settlement Agreement, the Company purchased back three patent license agreements (including territory rights) from Hydropress valued at approximately $287,000. The first license concerned the exclusive right to sell and use the N-Viro technology in Massachusetts, Vermont and New Hampshire. The second license concerned the non-exclusive right to sell and use the N-Viro technology in New Jersey, Delaware, Maryland and Eastern Pennsylvania. The third license concerned amendments to the two prior-mentioned agreements and the exclusive right to use the N-Viro technology at Hydropress' facility in Phillipsburg, New Jersey. N-Viro and Hydropress entered into a new patent license agreement granting Hydropress the non-exclusive right to use the N-Viro technology at its facility in Phillipsburg, New Jersey. The Company is paying certain amounts due to Hydropress under the Settlement Agreement pursuant to the terms of a promissory note (the "Note"). The original principal amount of the Note was $204,587. The Note is non-interest bearing and matures on October 15, 2002 with a balloon payment of $144,587. At June 30, 2002, the outstanding principal balance on the Note was $162,587. In 2001, officials of the North Carolina Department of Revenue (the "Department") contacted the Company and indicated that the Company was under investigation for failing to file sales tax returns in the state of North Carolina during the period from December 1994 to June 2001. The Company acknowledged to Department officials that during that period of time, it had collected approximately $80,000 in sales taxes from certain customers but had not collected sales tax from other customers in North Carolina. The Company submitted a memorandum to the Department arguing that no sales tax was due by the Company because the sales at issue were exempt from sales tax. The Department disagreed with this memorandum and levied a fine and civil penalty totaling approximately $70,000 plus interest due on the previous unremitted taxes, which the Company agreed to pay in lieu of litigation. As of June 30, 2002, the Company has remitted all sales tax due the State, and has paid the fine and interest. The Company has arranged to pay the balance of the civil penalty pursuant to a short-term payment schedule agreed to by the Department. The Company has voluntarily approached state tax authorities in South Carolina and acknowledged failing to file sales tax returns within that state. The Company has collected and accrued approximately $170,000 in sales tax from customers in South Carolina that has not been remitted to South Carolina tax authorities. The Company believes that the sales at issue are exempt from sales tax. The Company has retained counsel in South Carolina to assist it in negotiating a settlement of this matter. Prior to May 9, 2002, the Company's shares of voting, common stock were traded on the SmallCap Market of the National Association of Securities Dealers Automated Quotation System ("NASDAQ"). On Thursday, May 9, 2002, the Company received notice from the NASD that the Company's shares of voting, common stock would be de-listed effective with the open of business on May 10, 2002. In July, 2002 the Company decided not to pursue further appeal of the NASD's decision to de-list its voting common stock. Currently, the Company's shares of common stock are traded on the Over-The-Counter market. The Company does not anticipate that the delisting of its common stock from the Nasdaq SmallCap Market will have a material adverse effect on the financial condition or results of operations of the Company. The delisting of the Company's common stock from NASDAQ, however, may have a material adverse effect on the marketability of the Company's shares, as shares traded on the -6- Over-The-Counter market generally experience lower trading value than those traded on the organized exchanges. The Company's executive and administrative offices are located in Toledo, Ohio, under a lease that expires on December 31, 2002. The Company believes its relationship with its lessor is satisfactory. The total minimum rental commitment at June 30, 2002 is approximately $33,000. The total rental expense included in the statements of operations for the six months ended June 30, 2002 and 2001 is approximately $32,000 and $32,200, respectively. The Company's remaining minimum commitment under an agreement with a consultant (see Note 2 above) is $30,000, payable in cash or stock in 2002. During 1999, the Company entered into employment and consulting agreements with two officers of the Company. One employment agreement expired in July 2002 and the other will expire in June 2004. Future compensation amounts are to be determined annually by the Board. In addition, one of the agreements provides for payment of life insurance premiums and the provision of health insurance coverage to the officer and his spouse for their lives. The present value of estimated costs related to the provisions of this agreement total $139,000 at July 2002. The cost was recognized over the term of the employment agreement. The Company charged $25,464 to operations for the six months ended June 30, 2002 in conjunction with these agreements. The consulting agreements begin upon termination of the respective employment agreements and extend through July 2015 and June 2014, respectively. The agreements require the officers to provide minimum future services to be eligible for compensation. The Company is involved in legal proceedings and subject to claims which have arisen in the ordinary course of business. These actions, when concluded and determined, will not, in the opinion of management, have a material adverse effect upon the financial position, results of operations or cash flows of the Company. 4. NEW ACCOUNTING STANDARDS In June 1998, SFAS No. 133, "Accounting for Derivative Instruments and Hedging Activities," was issued. SFAS No. 133 establishes accounting and reporting standards for derivative instruments and hedging activities. SFAS No. 133, as amended by SFAS No. 137, is effective for all fiscal quarters of all fiscal years beginning after June 15, 2000. In June 2001, the Financial Accounting Standards Board ("FASB") issued SFAS No. 141, "Business Combinations." SFAS No. 141 requires the purchase method of accounting for business combinations initiated after June 30, 2001 and eliminates the pooling-of-interest method and further clarifies the criteria to recognize intangible assets separately from goodwill. In June 2001, FASB issued SFAS No. 142, "Goodwill and Other Intangible Assets." Under SFAS No. 142, goodwill and intangible assets deemed to have indefinite lives will no longer be amortized but will be subject to periodic impairment tests. Other intangible assets will continue to be amortized over their useful lives. SFAS No. 142 is effective for fiscal years beginning after December 15, 2001. In June 2001, FASB issued SFAS No. 143, "Accounting for Asset Retirement Obligations," which is effective the first quarter of fiscal year 2003. SFAS 143 addresses financial accounting and reporting for obligations associated with the retirement of long-lived assets and the associated asset retirement cost. In August 2001, FASB issued SFAS No. 144, "Accounting for the Impairment or Disposal of Long-lived Assets," which is effective the first quarter of fiscal year 2002. SFAS No. 144 modifies and expands the financial accounting and reporting for the impairment or disposal of long-lived assets other than goodwill. The adoption of SFAS Nos. 133, 141, 142 and 144 had no material effect on the Company's financial statements. The Company is still evaluating the impact of SFAS No. 143, but at this time does not believe its adoption will have a significant impact on the financial position and results of operations of the Company. -7- 5. SEGMENT INFORMATION EARNINGS VARIATION DUE TO BUSINESS CYCLES AND SEASONAL FACTORS. The Company's operating results can experience quarterly or annual variations due to business cycles, seasonality and other factors. The market price for its common stock may decrease if its operating results do not meet the expectations of the market. Currently, approximately 50% of the Company's revenue is from management operations, 47% from other domestic operations, 2% from research and development grants and the remaining 1% from foreign operations. Sales of the N-Viro technology are affected by general fluctuations in the business cycles in the United States and worldwide, instability of economic conditions (such as the current conditions in the Asia Pacific region and Latin America) and interest rates, as well as other factors. In addition, operating results of some of the Company's business segments are influenced, along with other factors such as interest rates, by particular business cycles and seasonality. COMPETITION. The Company does business in a highly competitive market and has fewer resources than most of its competitors. Businesses in this market compete within and outside the United States principally on the basis of price, product quality, custom design, technical support, reputation, equipment financing assistance and reliability. Competitive pressures and other factors could cause the Company to lose market share or could result in decreases in prices, either of which could have a material adverse effect on its financial position and results of operations. RISKS OF DOING BUSINESS IN OTHER COUNTRIES. The Company conducts business in markets outside the United States, and expects to continue to do so. In addition to the risk of currency fluctuations, the risks associated with conducting business outside the United States include: social, political and economic instability; slower payment of invoices; underdeveloped infrastructure; underdeveloped legal systems; and nationalization. The Company has not entered into any currency swap agreements which may reduce these risks. The Company may enter into such agreements in the future if it is deemed necessary to do so. Current economic and political conditions in the Asia Pacific and Middle East regions have affected the Company outlook for potential revenue there. The Company cannot predict the full impact of this economic instability, but it could have a material adverse effect on revenues and profits. The Company has determined that its reportable segments are those that are based on the Company's method of internal reporting, which segregates its business by product category and service lines. The Company's reportable segments are as follows: Management Operations - The Company provides employee and management services to operate the City of Toledo Sludge Treatment Facility. Other Domestic Operations - Sales of territory or site licenses and royalty fees to use N-Viro technology in the United States. Foreign Operations - Sale of territory or site licenses and royalty fees to use N-Viro technology in foreign countries. Research and Development - The Company contracts with Federal and State agencies to perform or assist in research and development on the Company's technology. The accounting policies of the segments are the same as the Company's significant accounting policies. Fixed assets generating specific revenue are identified with their respective segments and are accounted for as such in the internal accounting records. All other assets, including cash and other -8- current assets and all long-term assets, other than fixed assets, are identified with the Corporate segment. The Company allocates a total of approximately 6% of its labor cost contained in selling, general, and administrative expenses to the segments, to reflect the indirect cost of maintaining these segments. All of the net nonoperating income (expense) are non-apportionable and not allocated to a specific segment. The Company accounts for and analyzes the operating data for its segments generally by geographic location, with the exception of the Management Operations and Research and Development segments. These segments represent both a significant amount of business generated as well as a specific location and unique type of revenue. The next two segments are divided between domestic and foreign sources, as these segments differ in terms of environmental and municipal legal issues, nature of the waste disposal infrastructure, political climate, and availability of funds for investing in the Company's technology. These factors have not changed significantly over the past several years and are not expected to change in the near term. The Research and Development segment accounts for approximately 7% of the total revenue of the Company, and is unlike any other revenue, in that it is generated as a result of a specific project to conduct initial or additional ongoing research into the Company's emerging technologies. -9- The table below presents information about the segment profits and segment identifiable assets used by the chief operating decision makers of the Company for the periods ended June 30, 2002 and 2001 (dollars in thousands).
Other Management Domestic Foreign Research & Operations Operations Operations Development Total ----------------- --------------- --------------- ------------------ ----------- Quarter Ended June 30, 2002 --------------------------------------------------------------------------------- Revenues $ 622 $ 582 $ 12 $ 24 $ 1,240 Cost of revenues 361 507 - 10 878 Segment profits 261 75 12 14 362 Identifiable assets 365 79 - 47 491 Depreciation 13 10 - 2 25 Quarter Ended June 30, 2001 --------------------------------------------------------------------------------- Revenues $ 430 $ 614 $ 13 $ 59 $ 1,116 Cost of revenues 258 332 - 53 643 Segment profits 172 282 13 6 473 Identifiable assets 190 69 - 54 313 Depreciation 8 10 - 2 20 Year Ended June 30, 2002 --------------------------------------------------------------------------------- Revenues $ 1,141 $ 1,366 $ 25 $ 126 $ 2,658 Cost of revenues 744 970 1 111 1,826 Segment profits 397 396 24 15 832 Identifiable assets 365 79 - 47 491 Depreciation 21 20 - 4 45 Year Ended June 30, 2001 --------------------------------------------------------------------------------- Revenues $ 864 $ 1,269 $ 26 $ 119 $ 2,278 Cost of revenues 605 697 - 94 1,396 Segment profits 259 572 26 25 882 Identifiable assets 190 69 - 54 313 Depreciation 16 20 - 4 40
-10- A reconciliation of total segment revenues, cost of revenues, and segment profits to consolidated revenues, cost of revenues, and segment information to the consolidated financial statements for the quarters ended June 30, 2002 and 2001 is as follows (dollars in thousands):
Quarter Quarter Ended June Ended June 30, 2002 30, 2001 --------------- --------------- Segment profits: Segment profits for reportable segments $ 362 $ 473 Corporate selling, general and administrative expenses and research and development costs (512) (631) Other income (expense) 24 (45) --------------- --------------- Consolidated earnings before taxes $ (126) $ (203) =============== =============== Identifiable assets: Identifiable assets for reportable segments $ 491 $ 313 Corporate property and equipment 130 216 Current assets not allocated to segments 1,433 1,993 Intangible and other assets not allocated to segments 2,516 2,324 Consolidated eliminations (234) (234) --------------- --------------- Consolidated assets $4,336 $4,612 =============== =============== Depreciation and amortization: Depreciation for reportable segments $ 25 $ 20 Corporate depreciation and amortization 41 32 --------------- --------------- Consolidated depreciation and amortization $ 66 $ 52 =============== ===============
6. INVESTMENT IN FLORIDA N-VIRO, L. P. Florida N-Viro, L.P. was formed in January 1996 pursuant to a joint venture agreement between the Company and VFL Technology Corporation. The Company owns a 47.5% interest in the joint venture. Condensed financial information of the partnership for the quarters ended June 30, 2002 and 2001 is as follows:
Quarter Ended June 30, ------------------------------------- 2002 2001 ----------------- ------------------ Net sales $ 866,547 $ 741,080 Gross profit 122,434 (38,381) Income (loss) from continuing operations 58,139 (108,692) Net income (loss) 58,139 (108,692)
-11- ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS OVERVIEW The Company was incorporated in April, 1993, and became a public company on October 12, 1993. The Company's business strategy is to market the N-Viro Process, which produces an "exceptional quality" sludge product as defined in the Section 503 Sludge Regulations under the Clean Water Act of 1987, with multiple commercial uses. To date, the Company's revenues primarily have been derived from the licensing of the N-Viro Process to treat and recycle wastewater sludge generated by municipal wastewater treatment plants and from the sale to licensees of the alkaline admixture used in the N-Viro Process. The Company has also operated N-Viro facilities for third parties on a start-up basis and currently operates one N-Viro facility on a contract management basis. Total revenues were $1,240,000 for the quarter ended June 30, 2002 compared to $1,115,000 for the same period of 2001. The net increase in revenue is due primarily to an increase in revenues from service fees from the management of alkaline admixture and facility management. The Company's cost of revenues increased to $878,000 in 2002 from $643,000 for the same period in 2001, but the gross profit percentage decreased to 29% from 42% for the quarters ended June 30, 2002 and 2001. This decrease in gross profit percentage is primarily due to the increased share in revenues derived from both the service fee for the management of alkaline admixture and the facility management operation, both of which have a lower gross profit margin associated with them than other types of revenue, and the start-up of a soil blending operation in conjunction with the management fee operation. Operating expenses decreased for the comparative period, while the Company's share of the income of a joint venture, the Company's interest in Florida N-Viro, L.P., increased for the same period of 2002. These changes collectively resulted in a net loss of approximately $126,000 for the quarter ended June 30, 2002 compared to a net loss of $203,000 for the quarter ended June 30, 2001. COMPARISON OF THREE MONTHS ENDED JUNE 30, 2002 WITH THREE MONTHS ENDED JUNE 30, 2001 Overall revenue increased $125,000, or 11%, to $1,240,000 for the quarter ended June 30, 2002 from $1,115,000 for the quarter ended June 30, 2001. The net increase in revenue was due primarily to the following: a) Sales of alkaline admixture decreased $6,000 from the same period ended in 2001; b) Revenue from the service fees for the management of alkaline admixture was $132,000 for 2002. This type of revenue is the fee charged by the Company to manage and sell the alkaline admixture on behalf of a third party customer; c) The Company's processing revenue, including facility management revenue, showed a net increase of $35,000 over the same period ended in 2001; d) Miscellaneous revenues increased $2,000 from the same period ended in 2001; e) Licensing of the N-Viro Process, including territory fees, earned the Company $-0- for the period, the same as in 2001; and, f) Research and development revenue decreased $38,000 from the same period ended in 2001. Gross profit decreased $111,000, or 23%, to $362,000 for the three months ended June 30, 2002 from $473,000 for the three months ended June 30, 2001. This decrease in gross profit was primarily due to the increased percentage of total revenue derived from both the service fees for the management of -12- alkaline admixture and the facility management operation, both of which have a lower gross profit margin associated with them than other types of revenue of the Company. The gross profit margin decreased to 29% from 42%, mainly from the larger percentage of total revenue derived from the service fees for the management of alkaline admixture and facility management operations. In conjunction with the facility management operation, the Company also started a soil blending operation in the quarter, and expensed approximately $124,000 with no revenue. The Company expects this operation to realize revenue in the third quarter of 2002. If the Company had not started this operation, the gross margin would have been approximately 37%. Operating expenses decreased $119,000, or 19%, to $512,000 for the three months ended June 30, 2002 from $631,000 for the three months ended June 30, 2001. The decrease was primarily due to a decrease in patent litigation costs of $132,000. As a result of the foregoing factors, the Company recorded an operating loss of $150,000 for the three months ended June 30, 2002 compared to an operating loss of $158,000 for the three months ended June 30, 2001. Net nonoperating income (expense) increased by $69,000 to a net income of $24,000 for the three months ended June 30, 2002 from a net expense of $45,000 for the three months ended June 30, 2001. The increase was primarily due to an increase in the equity of a joint venture from a loss of $52,000 in 2001 to income of $28,000 in 2002. For the three months ended June 30, 2002 and 2001, the Company has not fully recognized the tax benefit of the losses incurred in prior periods. Accordingly, the effective tax rate for each period was zero. COMPARISON OF SIX MONTHS ENDED JUNE 30, 2002 WITH SIX MONTHS ENDED JUNE 30, 2001 Overall revenue increased $380,000, or 17%, to $2,658,000 for the six months ended June 30, 2002 from $2,278,000 for the six months ended June 30, 2001. The net increase in revenue was due primarily to the following: a) Sales of alkaline admixture increased $39,000 from the same period ended in 2001; b) Revenue from the service fees for the management of alkaline admixture was $268,000 for 2002. This type of revenue is new this year, and is the fee charged by the Company to manage and sell the alkaline admixture on behalf of a third party customer; c) The Company's processing revenue, including facility management revenue, showed a net decrease of $14,000 over the same period ended in 2001; d) Miscellaneous revenues decreased $6,000 from the same period ended in 2001; e) Licensing of the N-Viro Process, including territory fees, earned the Company $92,000 for the period, an increase of $92,000 from the same period in 2001; and, f) Research and development revenue increased $1,000 from the same period ended in 2001. Gross profit decreased $50,000, or 6%, to $832,000 for the six months ended June 30, 2002 from $882,000 for the six months ended June 30, 2001. This decrease in gross profit was primarily due to the increased percentage of total revenue derived from both the service fees from the management of alkaline admixture and facility management operation, both of which have a lower gross profit margin associated -13- with them than other types of revenue of the Company. The gross profit margin decreased to 31% from 39%, mainly from the larger percentage of total revenues derived from the service fees from the management of alkaline admixture and facility management operations. In conjunction with the facility management operation, the Company also started a soil blending operation in the second quarter, and expensed approximately $124,000 with no revenue. The Company expects this operation to realize revenue in the third quarter of 2002. If the Company had not started this operation, the gross margin for the six month period would have been approximately 35%. Operating expenses decreased $266,000, or 21%, to $982,000 for the six months ended June 30, 2002 from $1,248,000 for the six months ended June 30, 2001. The decrease was primarily due to a decreases in patent litigation costs of $202,000, and general office related expenses of $64,000. As a result of the foregoing factors, the Company recorded an operating loss of $150,000 for the six months ended June 30, 2002 compared to an operating loss of $366,000 for the six months ended June 30, 2001. Net nonoperating income (expense) increased by $104,000 to a net income of $48,000 for the six months ended June 30, 2002 from a net expense of $56,000 for the six months ended June 30, 2001. The increase was primarily due to an increase in the equity of a joint venture from a loss of $62,000 in 2001 to income of $52,000 in 2002. For the six months ended June 30, 2002 and 2001, the Company has not fully recognized the tax benefit of the losses incurred in prior periods. Accordingly, the effective tax rate for each period was zero. LIQUIDITY AND CAPITAL RESOURCES The Company had a working capital deficit of $1,120,000 at June 30, 2002, compared to a working capital deficit of $955,000 at December 31, 2001, which is an increase of $165,000. Current assets at June 30, 2002 included cash and investments of $444,000 (including restricted cash of $400,000), which is a decrease of $1,000 from December 31, 2001. The decrease in working capital was principally due to the operating loss for the six month period. The Company maintains a $400,000 certificate of deposit with a bank which is held as collateral on the Company's working capital line of credit. In April 2000, the Company renewed its agreement for a line of credit of $1 million, and in May 2001 the line was renewed for $750,000. The lender extended the line in April, 2002 and again July 31, 2002 and now expires January 31, 2003. The current agreement contains two demand Notes, for $400,000 and $350,000, each expiring January 31, 2003. The first Note is secured by a certificate of deposit with the lender of $400,000, and the second Note is secured by all business assets and the assignment of the contract between the City of Toledo and the Company, and requires the Company to maintain certain financial covenants.. Borrowings on the first Note bear interest at prime plus 1%, and borrowings on the second Note bear interest at prime plus 3%. The balance owed on the existing line at June 30, 2002 was $610,000. The normal collection terms for accounts receivable are approximately 30 or 60 days for a majority of the customers. This is a result of the nature of the license contracts and type of customer. The Company's cash requirements for the next 90 days include a balloon payment due Hydropress in October, 2002 and the remittance of sales tax to the State of South Carolina (see Note 3 discussions). The Company also expects to realize significant seasonal revenue from the sale of its soil products, and is -14- initiating a plan of immediate cost-cutting and other measures to improve its cash flow through the year end. The Company is currently negotiating with several third parties which may result in additional funds which, in management's opinion, would provide adequate cash flows to finance the Company's cash requirements. The satisfactory completion of these negotiations is essential as these avenues are the Company's principal means of providing sufficient cash flows to meet 2002 requirements. Because these negotiations are still in progress, there can be no assurance the Company will have sufficient funds to finance its operations. The Company has agreed to go forward on a contract with the investment banking firm of Laux & Company of Medina, Ohio, with respect to a proposal to obtain up to $1.25 million in equity financing. The Company hopes to sell up to 500,000 shares of preferred stock at a price per share of $2.50. The specific terms and conditions applicable to the preferred shares will be determined once Laux & Company has identified a potential purchaser. There can be no assurance that the Company will be successful in finding a buyer for the preferred stock or in selling these shares. If the shares are sold, the proceeds from the offering will be used to supplement the Company's working capital. Current market trends and Company business development provide significant basis for the Company's optimistic outlook for 2002 and beyond. The national public attack on Class B levels of sludge treatment is rapidly moving the market to Class A technologies, of which the Company's patented N-Viro processes are very cost competitive, and well established in the market place. The development and patenting of new technologies for animal manure treatment, bio-fuel and nematode control have the potential to expand the Company's revenue base over the next five years and beyond. The Company believes that its working capital together with the line of credit and satisfactory completion of negotiations with third parties will provide sufficient cash to meet the Company's cash requirements through 2002. OUR ABILITY TO GROW MAY BE LIMITED BY COMPETITION We provide a variety of technology and services relating to the transportation and treatment of wastewater residuals. We are in direct and indirect competition with other businesses that provide some or all of the same services including regional residuals management companies and national and international water and wastewater operations/privatization companies, technology suppliers, municipal solid waste companies and farming operations. Some of these competitors are larger and have greater capital resources than we do. We derive a substantial portion of our revenue from services provided under municipal contracts, and many of these are subject to competitive bidding. We also intend to bid on additional municipal contracts, however, we may not be the successful bidder. In addition, some of our contracts will expire in the future and those contracts may be renewed on less attractive terms. If we are not able to replace revenues from contracts lost through competitive bidding or from the renegotiation of existing contracts with other revenues within a reasonable time period, the lost revenue could have a material and adverse effect on our business and financial condition. WE ARE AFFECTED BY UNUSUALLY ADVERSE WEATHER CONDITIONS Our business is adversely affected by unusual weather conditions and unseasonably heavy rainfall which can temporarily reduce the availability of land application sites in close proximity to our business. In addition, our revenues and operational results are adversely affected during the winter months which -15- limits the level of land application that can be performed. Long periods of adverse weather could have a material negative effect on our business and financial condition. FUEL COST VARIATION COULD AFFECT OPERATING RESULTS AND EXPENSES The price and supply of fuel is unpredictable and fluctuates based on events outside our control, including demand for oil and gas, actions by OPEC and other oil and gas producers, and war in oil producing countries. Because fuel is needed to run the trucks that purchase the processing materials and supplies for our customers, price escalations or reductions in the supply of fuel could increase our operating expenses and have a negative impact on the results of operations. We are not always able to pass through all or part of the increased fuel costs due to the terms of certain customers' contracts and the inability to negotiate such pass through costs in a timely manner. WE ARE DEPENDENT ON THE MEMBERS OF OUR MANAGEMENT TEAM We are highly dependent on the services of our management team, the loss of any of whom may have a material adverse effect on our business and financial condition. We have entered into employment agreements with certain members of our management team, which contain non-compete and other provisions. The laws of each state differ concerning the enforceability of non-competition agreements. We cannot predict with certainty whether or not a court will enforce a non-compete covenant in any given situation based on the facts and circumstances at that time. If one of our key executive officers were to leave us and the courts refused to enforce the non-compete covenant, we might be subject to increased competition, which could have a material and adverse effect on our business and financial condition. OUR INTELLECTUAL PROPERTY MAY BE MISAPPROPRIATED OR SUBJECT TO CLAIMS OF INFRINGEMENT We attempt to protect our intellectual property rights through a combination of patent, trademark, and trade secret laws, as well as licensing agreements. Our failure to obtain or maintain adequate protection of our intellectual property rights for any reason could have a material adverse effect on our business and financial condition. Our competitors, many of whom have substantially greater resources and have made substantial investments in competing technologies, may have applied for or obtained, or may in the future apply for and obtain, patents that will prevent, limit or otherwise interfere with our ability to offer our services. We have not conducted an independent review of patents issued to third parties. We also rely on unpatented proprietary technology. It is possible that others will independently develop the same or similar technology or otherwise obtain access to our unpatented technology. If we are unable to maintain the proprietary nature of our technologies, we could be materially adversely affected. The Company cautions that words used in this document such as "expects," "anticipates," "believes," "may," and "optimistic," as well as similar words and expressions used herein, identify and refer to statements describing events that may or may not occur in the future. These forward-looking statements and the matters to which they refer are subject to considerable uncertainty that may cause actual results to be materially different from those described herein. Some, but not all, of the factors that could cause actual results to be different than those anticipated or predicted by the Company include: (i) a deterioration in economic conditions in general; (ii) a decrease in demand for the Company's products or services in particular; (iii) the Company's loss of a key employee or employees; (iv) regulatory changes, including changes in environmental regulations, that may have an adverse affect on the demand for the Company's products or services; (v) increases in the Company's operating expenses resulting from increased costs of labor and/or consulting services; and (vi) a failure to collect upon or otherwise -16- secure the benefits of existing contractual commitments with third parties, including customers of the Company. For example, while the Company anticipates obtaining the permits and approvals necessary for the N-Viro Fuel pilot program to commence operations in 2002, such program may not begin until 2003 or may never begin. Delay or cancellation with respect to this project could result from (1) a failure to achieve acceptable air quality levels in preliminary testing, (2) costs associated with the use of N-Viro Fuel significantly exceeding current estimates, or (3) competing technologies rendering the N-Viro Fuel process less attractive. -17- PART II - OTHER INFORMATION ITEM 1. LEGAL PROCEEDINGS In November, 2001, and as filed under Form 8-K dated December 14, 2001, the Company and Hydropress Environmental Services, Inc. ("Hydropress") signed a settlement agreement (the "Settlement Agreement") of a lawsuit between the parties related to alleged price guarantees on shares of the Company's common stock and to alleged breaches of a license agreement between the parties. Each party dismissed its claims against the other with prejudice and entered into general releases in favor of the other party. Pursuant to the terms of the Settlement Agreement, among other things, N-Viro purchased back 66,250 N-Viro shares held by Hydropress at the market price as of November 15, 2001, which was $1.01 per share, for a total of $66,913. Also pursuant to the Settlement Agreement, the Company purchased back three patent license agreements (including territory rights) from Hydropress valued at approximately $287,000. The first license concerned the exclusive right to sell and use the N-Viro technology in Massachusetts, Vermont and New Hampshire. The second license concerned the non-exclusive right to sell and use the N-Viro technology in New Jersey, Delaware, Maryland and Eastern Pennsylvania. The third license concerned amendments to the two prior-mentioned agreements and the exclusive right to use the N-Viro technology at Hydropress' facility in Phillipsburg, New Jersey. N-Viro and Hydropress entered into a new patent license agreement granting Hydropress the non-exclusive right to use the N-Viro technology at its facility in Phillipsburg, New Jersey. The Company is paying certain amounts due to Hydropress under the Settlement Agreement pursuant to the terms of a promissory note (the "Note"). The original principal amount of the Note was $204,587. The Note is non-interest bearing and matures on October 15, 2002 with a balloon payment of $144,587. At June 30, 2002, the outstanding principal balance on the Note was $162,587. In 2001, officials of the North Carolina Department of Revenue (the "Department") contacted the Company and indicated that the Company was under investigation for failing to file sales tax returns in the state of North Carolina during the period from December 1994 to June 2001. The Company acknowledged to Department officials that during that period of time, it had collected approximately $80,000 in sales taxes from certain customers but had not collected sales tax from other customers in North Carolina. The Company submitted a memorandum to the Department arguing that no sales tax was due by the Company because the sales at issue were exempt from sales tax. The Department disagreed with this memorandum and levied a fine and civil penalty totaling approximately $70,000 plus interest due on the previous unremitted taxes, which the Company agreed to pay in lieu of litigation. As of June 30, 2002, the Company has remitted all sales tax due the State, and has paid the fine and interest. The Company has arranged to pay the balance of the civil penalty pursuant to a short-term payment schedule agreed to by the Department. The Company has voluntarily approached state tax authorities in South Carolina and acknowledged failing to file sales tax returns within that state. The Company has collected and accrued approximately $170,000 in sales tax from customers in South Carolina that has not been remitted to South Carolina tax authorities. The Company believes that the sales at issue are exempt from sales tax. The Company has retained counsel in South Carolina to assist it in negotiating a settlement of this matter. Prior to May 9, 2002, the Company's shares of voting, common stock were traded on the SmallCap Market of the National Association of Securities Dealers Automated Quotation System ("NASDAQ"). On Thursday, May 9, 2002, the Company received notice from the NASD that the Company's shares of voting, common stock would be de-listed effective with the open of business on May 10, 2002. In July, 2002 the Company decided not to pursue further appeal of the NASD's decision to de-list its voting common stock. Currently, the Company's shares of common stock are traded on the Over-The-Counter market. The Company does not anticipate that the delisting of its common stock from the Nasdaq SmallCap Market will have a material adverse effect on the financial condition or results of -18- operations of the Company. The delisting of the Company's common stock from NASDAQ, however, may have a material adverse effect on the marketability of the Company's shares, as shares traded on the Over-The-Counter market generally experience lower trading value than those traded on the organized exchanges. ITEM 2. CHANGES IN SECURITIES AND USE OF PROCEEDS None ITEM 3. DEFAULTS UPON SENIOR SECURITIES None ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS None ITEM 5. OTHER INFORMATION None. ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K (a) Exhibits: Exhibit 99.1 - Certification(s) Pursuant to Section 1350 of Chapter 63 of Title 18 of the United States Code. (b) Reports on Form 8-K: The Company filed a report on Form 8-K dated April 25, 2002, to disclose both the signing of agreements with one of the Company's stockholders, and the retention of an investment banking firm to assist in the issuance of shares of preferred stock. -19- N-VIRO INTERNATIONAL CORPORATION Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. N-VIRO INTERNATIONAL CORPORATION Date: August 14, 2002 /s/ Terry J. Logan --------------------- ------------------------------------------ Terry J. Logan Chief Executive Officer and President (Principal Executive Officer) Date: August 14, 2002 /s/ James K. McHugh --------------------- ------------------------------------------ James K. McHugh Chief Financial Officer, Secretary and Treasurer (Principal Financial & Accounting Officer) -20-